annual EBIT:
-$463.93M-$61.66M(-15.33%)Summary
- As of today (July 3, 2025), PCVX annual earnings before interest & taxes is -$463.93 million, with the most recent change of -$61.66 million (-15.33%) on December 31, 2024.
- During the last 3 years, PCVX annual EBIT has fallen by -$363.86 million (-363.60%).
- PCVX annual EBIT is now -1477.45% below its all-time high of -$29.41 million, reached on December 31, 2018.
Performance
PCVX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$180.79M-$123.43M(-215.18%)Summary
- As of today (July 3, 2025), PCVX quarterly earnings before interest & taxes is -$180.79 million, with the most recent change of -$123.43 million (-215.18%) on March 31, 2025.
- Over the past year, PCVX quarterly EBIT has dropped by -$66.32 million (-57.94%).
- PCVX quarterly EBIT is now -1596.95% below its all-time high of -$10.65 million, reached on June 30, 2019.
Performance
PCVX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$530.37M-$66.32M(-14.29%)Summary
- As of today (July 3, 2025), PCVX TTM earnings before interest & taxes is -$530.37 million, with the most recent change of -$66.32 million (-14.29%) on March 31, 2025.
- Over the past year, PCVX TTM EBIT has dropped by -$84.17 million (-18.86%).
- PCVX TTM EBIT is now -3783.25% below its all-time high of -$13.66 million, reached on March 31, 2019.
Performance
PCVX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PCVX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.3% | -57.9% | -18.9% |
| 3 y3 years | -363.6% | -362.9% | -349.8% |
| 5 y5 years | -823.5% | -566.3% | -622.8% |
PCVX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -363.6% | at low | -272.5% | at low | -271.5% | +2.2% |
| 5 y | 5-year | -823.5% | at low | -789.7% | at low | -622.8% | +2.2% |
| alltime | all time | -1477.5% | at low | -1597.0% | at low | -3783.3% | +2.2% |
PCVX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$180.79M(+215.2%) | -$530.37M(+14.3%) |
| Dec 2024 | -$463.93M(+15.3%) | -$57.36M(-58.9%) | -$464.05M(-14.4%) |
| Sep 2024 | - | -$139.63M(-8.5%) | -$542.35M(+5.5%) |
| Jun 2024 | - | -$152.59M(+33.3%) | -$514.11M(+15.2%) |
| Mar 2024 | - | -$114.47M(-15.6%) | -$446.20M(+10.9%) |
| Dec 2023 | -$402.27M(+80.0%) | -$135.66M(+21.8%) | -$402.27M(+16.7%) |
| Sep 2023 | - | -$111.39M(+31.5%) | -$344.66M(+18.4%) |
| Jun 2023 | - | -$84.68M(+20.1%) | -$291.19M(+14.2%) |
| Mar 2023 | - | -$70.54M(-9.6%) | -$255.03M(+14.1%) |
| Dec 2022 | -$223.48M(+123.3%) | -$78.05M(+34.8%) | -$223.56M(+28.4%) |
| Sep 2022 | - | -$57.92M(+19.3%) | -$174.07M(+21.9%) |
| Jun 2022 | - | -$48.53M(+24.2%) | -$142.77M(+21.1%) |
| Mar 2022 | - | -$39.06M(+36.8%) | -$117.91M(+15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$100.07M(+12.2%) | -$28.56M(+7.3%) | -$101.99M(+8.3%) |
| Sep 2021 | - | -$26.61M(+12.4%) | -$94.17M(+6.3%) |
| Jun 2021 | - | -$23.67M(+2.3%) | -$88.57M(+3.9%) |
| Mar 2021 | - | -$23.14M(+11.6%) | -$85.22M(-4.5%) |
| Dec 2020 | -$89.21M(+77.6%) | -$20.74M(-1.3%) | -$89.21M(+7.4%) |
| Sep 2020 | - | -$21.02M(+3.4%) | -$83.09M(+13.2%) |
| Jun 2020 | - | -$20.32M(-25.1%) | -$73.38M(+15.2%) |
| Mar 2020 | - | -$27.14M(+85.7%) | -$63.71M(+26.8%) |
| Dec 2019 | -$50.23M(+70.8%) | -$14.61M(+29.2%) | -$50.23M(+41.0%) |
| Sep 2019 | - | -$11.31M(+6.1%) | -$35.62M(+46.5%) |
| Jun 2019 | - | -$10.65M(-22.0%) | -$24.31M(+78.0%) |
| Mar 2019 | - | -$13.66M | -$13.66M |
| Dec 2018 | -$29.41M | - | - |
FAQ
- What is Vaxcyte annual earnings before interest & taxes?
- What is the all time high annual EBIT for Vaxcyte?
- What is Vaxcyte annual EBIT year-on-year change?
- What is Vaxcyte quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Vaxcyte?
- What is Vaxcyte quarterly EBIT year-on-year change?
- What is Vaxcyte TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Vaxcyte?
- What is Vaxcyte TTM EBIT year-on-year change?
What is Vaxcyte annual earnings before interest & taxes?
The current annual EBIT of PCVX is -$463.93M
What is the all time high annual EBIT for Vaxcyte?
Vaxcyte all-time high annual earnings before interest & taxes is -$29.41M
What is Vaxcyte annual EBIT year-on-year change?
Over the past year, PCVX annual earnings before interest & taxes has changed by -$61.66M (-15.33%)
What is Vaxcyte quarterly earnings before interest & taxes?
The current quarterly EBIT of PCVX is -$180.79M
What is the all time high quarterly EBIT for Vaxcyte?
Vaxcyte all-time high quarterly earnings before interest & taxes is -$10.65M
What is Vaxcyte quarterly EBIT year-on-year change?
Over the past year, PCVX quarterly earnings before interest & taxes has changed by -$66.32M (-57.94%)
What is Vaxcyte TTM earnings before interest & taxes?
The current TTM EBIT of PCVX is -$530.37M
What is the all time high TTM EBIT for Vaxcyte?
Vaxcyte all-time high TTM earnings before interest & taxes is -$13.66M
What is Vaxcyte TTM EBIT year-on-year change?
Over the past year, PCVX TTM earnings before interest & taxes has changed by -$84.17M (-18.86%)